409 related articles for article (PubMed ID: 33868485)
1. Clinical value of lncRNA CCAT1 in serum extracellular vesicles as a potential biomarker for gastric cancer.
Xiao K; Dong Z; Wang D; Liu M; Ding J; Chen W; Shang Z; Yue C; Zhang Y
Oncol Lett; 2021 Jun; 21(6):447. PubMed ID: 33868485
[TBL] [Abstract][Full Text] [Related]
2. Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach.
Mizrahi I; Mazeh H; Grinbaum R; Beglaibter N; Wilschanski M; Pavlov V; Adileh M; Stojadinovic A; Avital I; Gure AO; Halle D; Nissan A
J Cancer; 2015; 6(2):105-10. PubMed ID: 25561974
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical value of circRNAs in serum extracellular vesicles for gastric cancer.
Xiao K; Li S; Ding J; Wang Z; Wang D; Cao X; Zhang Y; Dong Z
Front Oncol; 2022; 12():962831. PubMed ID: 36059681
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle-Transported Long Non-Coding RNA (LncRNA) X Inactive-Specific Transcript (XIST) in Serum is a Potential Novel Biomarker for Colorectal Cancer Diagnosis.
Yu J; Dong W; Liang J
Med Sci Monit; 2020 Aug; 26():e924448. PubMed ID: 32843612
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.
Li Y; Zhu G; Ma Y; Qu H
J Cell Biochem; 2017 Dec; ():. PubMed ID: 29231252
[TBL] [Abstract][Full Text] [Related]
6. lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.
Li Y; Zhu G; Ma Y; Qu H
J Cell Biochem; 2019 Dec; 120(12):19457-19468. PubMed ID: 31478245
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
Zhang XF; Liu T; Li Y; Li S
Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of long non-coding RNA CCAT1 in gastric cancer].
Shan T; Chen YG; Hong B; Zhou H; Xia JZ
Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1411-1414. PubMed ID: 28535628
[No Abstract] [Full Text] [Related]
9. Long noncoding RNA colon cancer associated transcript‑1 promotes the proliferation, migration and invasion of cervical cancer.
Jia L; Zhang Y; Tian F; Chu Z; Xin H
Mol Med Rep; 2017 Oct; 16(4):5587-5591. PubMed ID: 28849215
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression of Lncrna RP11-397A15.4 in Gastric Cancer and Its Clinical Significance.
Chen H; Xu Z; Liu X; Gao Y; Wang J; Qian P; Yang B
Ann Clin Lab Sci; 2018 Nov; 48(6):707-711. PubMed ID: 30610039
[TBL] [Abstract][Full Text] [Related]
11. Combined identification of LncRNA CCAT1 and SOX2OT in serum as an effective screening for non-small cell lung cancer.
Wang Z; Li J; Wu Y; Wang H
Int J Clin Exp Pathol; 2019; 12(10):3975-3981. PubMed ID: 31933793
[TBL] [Abstract][Full Text] [Related]
12. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
Lai XJ; Cheng HF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement.
Zhang C; Wang H; Liu Q; Dai S; Tian G; Wei X; Li X; Zhao L; Shan B
J Exp Clin Cancer Res; 2023 Sep; 42(1):246. PubMed ID: 37740243
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer.
Zhang K; Shi H; Xi H; Wu X; Cui J; Gao Y; Liang W; Hu C; Liu Y; Li J; Wang N; Wei B; Chen L
Theranostics; 2017; 7(1):213-227. PubMed ID: 28042329
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
Abedini P; Fattahi A; Agah S; Talebi A; Beygi AH; Amini SM; Mirzaei A; Akbari A
J Cell Physiol; 2019 Dec; 234(12):22028-22033. PubMed ID: 31093977
[TBL] [Abstract][Full Text] [Related]
17. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of long noncoding RNA CCAT1 inhibits cell growth, invasion and peritoneal metastasis via downregulation of Bmi-1 in gastric cancer.
Li N; Jiang K; Fang LP; Yao LL; Yu Z
Neoplasma; 2018 Sep; 65(5):736-744. PubMed ID: 29940756
[TBL] [Abstract][Full Text] [Related]
19. Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma.
Dong Y; Yuan H; Jin G
Oncol Lett; 2018 Aug; 16(2):2750-2756. PubMed ID: 30013670
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.
Caivano A; La Rocca F; Simeon V; Girasole M; Dinarelli S; Laurenzana I; De Stradis A; De Luca L; Trino S; Traficante A; D'Arena G; Mansueto G; Villani O; Pietrantuono G; Laurenti L; Del Vecchio L; Musto P
Cell Oncol (Dordr); 2017 Feb; 40(1):97-103. PubMed ID: 27761889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
